|
|
|
|
LEADER |
01000caa a22002652 4500 |
001 |
NLM098644122 |
003 |
DE-627 |
005 |
20250201010211.0 |
007 |
tu |
008 |
231222s1998 xx ||||| 00| ||eng c |
028 |
5 |
2 |
|a pubmed25n0329.xml
|
035 |
|
|
|a (DE-627)NLM098644122
|
035 |
|
|
|a (NLM)9929295
|
040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
041 |
|
|
|a eng
|
100 |
1 |
|
|a Smith, D S
|e verfasserin
|4 aut
|
245 |
1 |
0 |
|a Therapy planning as constraint satisfaction
|b a computer-based antiretroviral therapy advisor for the management of HIV
|
264 |
|
1 |
|c 1998
|
336 |
|
|
|a Text
|b txt
|2 rdacontent
|
337 |
|
|
|a ohne Hilfsmittel zu benutzen
|b n
|2 rdamedia
|
338 |
|
|
|a Band
|b nc
|2 rdacarrier
|
500 |
|
|
|a Date Completed 16.03.1999
|
500 |
|
|
|a Date Revised 13.11.2018
|
500 |
|
|
|a published: Print
|
500 |
|
|
|a Citation Status MEDLINE
|
520 |
|
|
|a We applied the Protégé methodology for building knowledge-based systems to the domain of antiretroviral therapy. We modeled the task of prescribing drug therapy for HIV, abstracting the essential characteristics of the problem solving. We mapped our model of the antiretroviral-therapy domain to the class of constraint-satisfaction problems, and reused the propose-and-revise problem-solving method, from the Protégé library of methods, to build an antiretroviral therapy advisor, ART Critic. Careful modeling and using Protégé allowed us to build a useful and extensible knowledge-based application rapidly
|
650 |
|
4 |
|a Journal Article
|
650 |
|
4 |
|a Research Support, Non-U.S. Gov't
|
650 |
|
4 |
|a Research Support, U.S. Gov't, Non-P.H.S.
|
650 |
|
4 |
|a Research Support, U.S. Gov't, P.H.S.
|
650 |
|
7 |
|a Anti-HIV Agents
|2 NLM
|
700 |
1 |
|
|a Park, J Y
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Musen, M A
|e verfasserin
|4 aut
|
773 |
0 |
8 |
|i Enthalten in
|t Proceedings. AMIA Symposium
|d 1998
|g (1998) vom: 13., Seite 627-31
|w (DE-627)NLM098642928
|x 1531-605X
|7 nnns
|
773 |
1 |
8 |
|g year:1998
|g day:13
|g pages:627-31
|
912 |
|
|
|a GBV_USEFLAG_A
|
912 |
|
|
|a SYSFLAG_A
|
912 |
|
|
|a GBV_NLM
|
912 |
|
|
|a GBV_ILN_350
|
951 |
|
|
|a AR
|
952 |
|
|
|j 1998
|b 13
|h 627-31
|